OTLK Chart
See on advanced chart >
About
Outlook Therapeutics, Inc. was incorporated in New Jersey on January 5, 2010.The company is a late clinical-stage biopharmaceutical company working to develop the first ophthalmic formulation of bevacizumab approved by the U.S. Food and Drug Administration,...
Read More
- HighlightA clinical-stage biopharmaceutical company focused on developing monoclonal antibodies for various ophthalmic indications
- ExchangeNASDAQ
- Listing Date06/14/2016
- Established Date01/05/2010
- Full-time Employees24
- Address485 Route 1 South Building F Suite 320 Iselin New Jersey
- Tel1-609-6193990
- Website
- Fiscal Year End Date09/30
- Security TypeCommon Stock
Industry
Pharmaceuticals